Full Press Release Details
BridgeBio Pharma's Origin Biosciences Presents New Data On The Natural History Of Molybdenum Cofactor Deficiency (MoCD) Type A At The SSIEM Conference.
BBIO
BridgeBio Pharma's Origin Biosciences Presents New Data On The Natural History Of Molybdenum Cofactor Deficiency (MoCD) Type A At The SSIEM Conference
Key Takeaway: BridgeBio Pharma's Origin Biosciences Presents New Data On The Natural History Of Molybdenum Cofactor Deficiency (MoCD) Type A At The SSIEM Conference